SCHEMBL21532295

SCHEMBL21532295

c1ccc(-c2nnc(-c3ccccc3)n2-c2ccc3c4ccccc4n(-c4cccc(-c5cccc(-n6c7ccccc7c7ccc8c9ccccc9oc8c76)c5)c4)c3c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.36
LMNA P02545 3/20 0.36
HPGD P15428 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MAPK1 P28482 2/20 0.36
KDM4E B2RXH2 4/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
HSD17B10 Q99714 4/20 0.34
TSHR P16473 3/20 0.34
OPRD1 P41143 2/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
GAA P10253 1/20 0.33
PPARG P37231 2/20 0.32
RXFP1 Q9HBX9 2/20 0.32
NR2E3 Q9Y5X4 2/20 0.32
NCOR2 Q9Y618 2/20 0.32
AVPR1A P37288 1/20 0.32
DRD4 P21917 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21532606 0.97 ALDH1A1 (0.36) ALDH1A1LMNAHPGDSMN1; SMN2MAPK1
SCHEMBL21532297 0.95 ALDH1A1 (0.35) ALDH1A1LMNAHPGDSMN1; SMN2MAPK1
SCHEMBL21532405 0.95 KDM4E (0.36) ALDH1A1LMNAHPGDSMN1; SMN2MAPK1
SCHEMBL21532548 0.92 ALOX5 (0.35) ALDH1A1LMNAHPGDSMN1; SMN2MAPK1
SCHEMBL21532202 0.92 ALDH1A1 (0.36) ALDH1A1LMNAHPGDSMN1; SMN2MAPK1
SCHEMBL21532715 0.92 KDM4E (0.37) ALDH1A1LMNAHPGDSMN1; SMN2MAPK1
SCHEMBL21532406 0.91 KDM4E (0.35) ALDH1A1LMNAHPGDSMN1; SMN2MAPK1
SCHEMBL21532304 0.91 ALDH1A1 (0.36) ALDH1A1LMNAHPGDSMN1; SMN2MAPK1
SCHEMBL21532683 0.90 ALDH1A1 (0.37) ALDH1A1LMNAHPGDSMN1; SMN2MAPK1
SCHEMBL15583049 0.89 KDM4E (0.42) ALDH1A1LMNAKDM4EATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-10-12 US disclosed
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same CRY1, CCNT1, CCNA1 ALDH1A1 158/4885LMNA 900/4885HPGD 3627/4885
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNT1, ARL1 ALDH1A1 283/4885LMNA 1120/4885HPGD 4204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.